SK11797A3 - Cyclopeptolides, process for their preparation and their use in therapy - Google Patents

Cyclopeptolides, process for their preparation and their use in therapy Download PDF

Info

Publication number
SK11797A3
SK11797A3 SK117-97A SK11797A SK11797A3 SK 11797 A3 SK11797 A3 SK 11797A3 SK 11797 A SK11797 A SK 11797A SK 11797 A3 SK11797 A3 SK 11797A3
Authority
SK
Slovakia
Prior art keywords
formula
leu
compounds
group
substituted
Prior art date
Application number
SK117-97A
Other languages
English (en)
Slovak (sk)
Inventor
Michael M Dreyfuss
Carolyn A Foster
Hans-Ulrich Naegeli
Berndt Oberhauser
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415168A external-priority patent/GB9415168D0/en
Priority claimed from GBGB9504332.9A external-priority patent/GB9504332D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of SK11797A3 publication Critical patent/SK11797A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
SK117-97A 1994-07-27 1995-07-26 Cyclopeptolides, process for their preparation and their use in therapy SK11797A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415168A GB9415168D0 (en) 1994-07-27 1994-07-27 Organic compounds
GBGB9504332.9A GB9504332D0 (en) 1995-03-03 1995-03-03 Organic compounds
PCT/EP1995/002966 WO1996003430A1 (en) 1994-07-27 1995-07-26 Organic compounds

Publications (1)

Publication Number Publication Date
SK11797A3 true SK11797A3 (en) 1997-07-09

Family

ID=26305345

Family Applications (1)

Application Number Title Priority Date Filing Date
SK117-97A SK11797A3 (en) 1994-07-27 1995-07-26 Cyclopeptolides, process for their preparation and their use in therapy

Country Status (26)

Country Link
US (1) US6013627A (xx)
EP (1) EP0775158B1 (xx)
JP (1) JP3425763B2 (xx)
KR (1) KR100378974B1 (xx)
CN (1) CN1116304C (xx)
AT (1) ATE187461T1 (xx)
AU (1) AU702332B2 (xx)
BR (1) BR9508342A (xx)
CA (1) CA2192786C (xx)
CY (1) CY2225B1 (xx)
CZ (1) CZ289311B6 (xx)
DE (1) DE69513837T2 (xx)
DK (1) DK0775158T3 (xx)
ES (1) ES2142490T3 (xx)
FI (1) FI970279A0 (xx)
GR (1) GR3032698T3 (xx)
HK (1) HK1014011A1 (xx)
HU (1) HUT77388A (xx)
MX (1) MX9606494A (xx)
NO (1) NO970340D0 (xx)
NZ (1) NZ291168A (xx)
PL (1) PL181990B1 (xx)
PT (1) PT775158E (xx)
RU (1) RU2155772C2 (xx)
SK (1) SK11797A3 (xx)
WO (1) WO1996003430A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
WO1999014082A1 (en) 1996-09-18 1999-03-25 Minnesota Mining And Manufacturing Company Adhesively-bonded inflatable restraint and method of making
US6365619B1 (en) 1999-07-22 2002-04-02 Novartis Ag Treatment of arteriosclerosis
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
AU783158B2 (en) * 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
WO2002034283A2 (en) * 2000-10-27 2002-05-02 Novartis Ag Vegh inhibitors and their use
GB0028367D0 (en) * 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
GB0101598D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
EP3008192B1 (en) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase
US4425428A (en) * 1982-04-08 1984-01-10 Monsanto Company Novel peptide and peptolide substrates for mammalian collagenase
ATE110784T1 (de) * 1987-06-19 1994-09-15 Sandoz Ag Zyklische peptolide.
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
GR3032698T3 (en) 2000-06-30
CA2192786C (en) 2009-06-16
CZ22197A3 (en) 1997-05-14
EP0775158B1 (en) 1999-12-08
EP0775158A1 (en) 1997-05-28
DE69513837T2 (de) 2000-05-18
KR100378974B1 (ko) 2003-10-08
ATE187461T1 (de) 1999-12-15
JP3425763B2 (ja) 2003-07-14
PL181990B1 (pl) 2001-10-31
MX9606494A (es) 1997-03-29
FI970279A (fi) 1997-01-23
AU3222195A (en) 1996-02-22
NO970340L (no) 1997-01-27
BR9508342A (pt) 1997-10-21
AU702332B2 (en) 1999-02-18
WO1996003430A1 (en) 1996-02-08
NZ291168A (en) 1998-06-26
CZ289311B6 (cs) 2001-12-12
HK1014011A1 (en) 1999-09-17
RU2155772C2 (ru) 2000-09-10
FI970279A0 (fi) 1997-01-23
HUT77388A (hu) 1998-04-28
CA2192786A1 (en) 1996-02-08
PL317349A1 (en) 1997-04-01
DE69513837D1 (de) 2000-01-13
CN1116304C (zh) 2003-07-30
DK0775158T3 (da) 2000-05-22
CN1154705A (zh) 1997-07-16
NO970340D0 (no) 1997-01-27
PT775158E (pt) 2000-05-31
CY2225B1 (en) 2003-04-18
ES2142490T3 (es) 2000-04-16
US6013627A (en) 2000-01-11
JPH10504540A (ja) 1998-05-06

Similar Documents

Publication Publication Date Title
SK11797A3 (en) Cyclopeptolides, process for their preparation and their use in therapy
US5643869A (en) Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
KR101566046B1 (ko) 환형 화합물을 생산하는 미생물
US5338758A (en) Bicyclic diterpene PAF antagonist compounds
CA2237157C (en) Cyclopeptolide inhibitors of adhesion molecules
US6583171B1 (en) Antineoplastic agents
AU738970B2 (en) Novel antibiotic, feglymycin, processes for its preparation and its use
KR0159643B1 (ko) 항암 및 항진균 화합물 및 이를 포함하는 약학적 조성물
US7112581B2 (en) Macrocyclic lactams
JPH06228040A (ja) 抗インフルエンザa活性クパラン型セスキテルペン化合物
JPH08301862A (ja) Penicillium種の抗生物質シリアノンおよびその化学誘導体並びにその製造法および使用
WO2004087938A1 (ja) 新規生理活性物質pf1270a、bおよびc物質
JPH06263789A (ja) 新規イソテトラセノン系物質及びその製造法
JPH0987269A (ja) アセトフタリジン、細胞周期阻害剤および抗腫瘍剤